In vitro invasion of small-cell lung cancer cell lines and EGFR expression
Author Information
Author(s): L Damstrup, B Rude Voldborg, M Spang-Thomsen, N Brnnner, H Skovgaard Poulsen
Primary Institution: University Hospital Copenhagen, Rigshospitalet
Hypothesis
The epidermal growth factor receptor (EGFR) plays a critical role in the invasion potential of small-cell lung cancer (SCLC) cell lines.
Conclusion
The study found that only EGFR-positive SCLC cell lines exhibited the ability to invade, suggesting that EGFR is important for their invasive potential.
Supporting Evidence
- All EGFR-positive SCLC cell lines were invasive, while none of the EGFR-negative cell lines could traverse the Matrigel membrane.
- In vitro invasion was significantly reduced in EGFR-positive cell lines when treated with an EGFR-neutralizing antibody.
- Quantified invasion assays showed that EGFR-positive cell lines had a higher percentage of cells traversing the Matrigel compared to EGFR-negative lines.
Takeaway
This study looked at cancer cells in a lab to see if a specific protein called EGFR helps them move and spread. They found that only the cells with this protein could move through a barrier.
Methodology
The study used a Boyden chamber assay to analyze the in vitro invasion of 21 SCLC cell lines and correlated the results with EGFR expression.
Limitations
The study did not establish a clear expression pattern of proteolytic enzymes that could distinguish invasive from non-invasive SCLC cell lines.
Participant Demographics
The study involved 21 SCLC cell lines established from 17 patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website